Scientific Publication

Elephas Biosciences' live-tissue platform achieves 93% accuracy in predicting immunotherapy response, paving a lucrative path for functional precision oncology.

SpotitEarly's Bio-AI platform combines canine scent detection with machine learning to spot early-stage cancer. Will regulatory hurdles stall its 2027 launch?

To trust AI with our economy, we need more than probabilistic models. We need deterministic systems that understand what business data actually means.

Immuron’s Phase 2 Travelan trial missed its primary endpoint, but a 71% drop in antibiotic use has the Pentagon and microbiome experts paying close attention.

A new pilot program pairs youth with homebound seniors to combat isolation, proving that our most critical urban infrastructure might just be human connection.

A new three-tier triage framework aims to protect prostate cancer patients from the lethal cardiovascular risks of life-extending hormone therapies.

With a newly published pediatric case study and a recent $50 million funding lifeline, Quoin Pharmaceuticals is racing to deliver the first approved therapy for Netherton Syndrome.

With a $50B market in play, NFL Biosciences is leveraging predictive biomarkers and novel neurobiology to disrupt the stagnant smoking cessation landscape.

New clinical data published in the Journal of Fungi reveals Moberg Pharma's MOB-015 overcomes terbinafine resistance, unlocking massive market potential.

Antengene’s novel masked CD2 costimulatory platform aims to solve immunotherapy's biggest bottleneck: cytokine toxicity and systemic overheating.

MiNK Therapeutics reveals new preclinical data on off-the-shelf iNKT therapies, targeting treatment-resistant colorectal cancer and senescent tumor cells.

A new peer-reviewed study validates RenovoRx's targeted catheter platform, offering a strategic bridge as the company approaches its 2027 Phase III readout.

ViCentra's latest real-world data reveals exceptional glucose control, positioning its design-first Kaleido pump to challenge major medtech incumbents.

Quorum Innovations has published early human data on Qi601, a postbiotic designed to trap microplastics in the gut before they enter human cells.

Appier's new SMITH framework, accepted at NeurIPS, lets small AI models build their own tools—cutting enterprise token costs by an astonishing 97%.

As climate risks threaten China’s $2 trillion Greater Bay Area, a new coalition is turning wetlands and oyster reefs into bankable, hard infrastructure.

Novo Nordisk’s new data shows patients successfully switching from injectable GLP-1s to a daily pill. But what does this mean for the $100B obesity market?

Aerospace-grade metals have turned stuck rings into medical emergencies. A new study reveals how a Canadian medtech startup is closing the dangerous technology gap in our trauma bays.

Dongguk University researchers have developed a flexible, battery-free neuromorphic sensor that converts physical touch into synaptic computing power.

A new study reveals it takes nearly 10 workdays to read the privacy terms of a single digital day. Has the "notice and consent" model completely collapsed?